您的位置: 首页 > 农业专利 > 详情页

VACCIN VIVANT ATTÉNUÉ SANS FACTEUR DE VIRULENCE ET ADAPTÉ AU FROID APPROPRIÉ À UNE ADMINISTRATION MUCOSALE
专利权人:
Emerging Viral Vaccine (HK) Limited;Versitech Limited
发明人:
LAU, Johnson Yiu-Nam,CHEN, Honglin,ZHENG, Min,WANG, Pui,YUEN, Kwok Yung
申请号:
EP17786481
公开号:
EP3445398A4
申请日:
2017.04.18
申请国别(地区):
EP
年份:
2020
代理人:
摘要:
Compositions and methods are provided for a live, attenuated influenza vaccine suitable for nasal administration. The vaccine utilizes a cold adapted influenza virus that lacks virulence factor, and includes mutations that provide replicative ability sufficient for vaccine manufacture. Vaccines so produced provide significant cross protection for non-vaccinating strains. The vaccine is safe for children under the age of 2 and adults over 49 years of age. In addition, the cold adapted, virulence factor deleted influenza virus can be adapted to provide immunity to non-influenza pathogens.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充